Slingshot members are tracking this event:
Interim Analysis of REDUCE-IT Cardiovascular Outcomes Trial of Vescepa Expected Late 2016
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Sep 12, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Vascepa, Triglycerides, Statin Therapy, Icosapent Ethyl, Interim Analysis